ArticleGene therapy2025
Recombinant oncolytic virus NDV-anti-VEGFR2 enhances radiotherapy sensitivity in NSCLC by targeting VEGF signaling and impairing DNA repair.
Liang Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it